Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)-Reference-Cited by-同舟云学术

Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)

Published:2017-06-26 Issue:1 Volume:17 Page:
ISSN:1471-244X
Container-title:BMC Psychiatry
language:en
Short-container-title:BMC Psychiatry

Author:

Marwood L.^ORCID,Taylor R.,Goldsmith K.,Romeo R.,Holland R.,Pickles A.,Hutchinson J.,Dietch D.,Cipriani A.,Nair R.,Attenburrow M.-J.,Young A. H.,Geddes J.,McAllister-Williams R. H.,Cleare A. J.

Funder

Health Technology Assessment Programme (GB)

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/s12888-017-1393-0.pdf

Reference52 articles.

1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–105.

2. Ustün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry J Ment Sci. 2004;184:386–92.

3. Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol Oxf Engl. 2015;29:459–525.